Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.49
+1.311.20%
Post-market: 110.24-0.2500-0.23%19:35 EDT
Volume:273.50K
Turnover:30.13M
Market Cap:1.03B
PE:89.53
High:110.70
Open:109.16
Low:108.66
Close:109.18
52wk High:118.00
52wk Low:90.60
Shares:9.34M
Float Shares:9.34M
Volume Ratio:0.90
T/O Rate:2.93%
Dividend:2.14
Dividend Rate:1.94%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.30

Loading ...

OverviewCompanyNewsFilings

Merck announces one-year results from Phase 2b/3 Brunello trial

TIPRANKS
·
1 hour ago

AbbVie Says Phase 3 Affirm Study Shows Subcutaneous Skyrizi Beats Placebo on Crohn’s Remission, Endoscopic Response at Week 12

Reuters
·
4 hours ago

Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial

Simply Wall St.
·
Yesterday

Merck Says Remigromig Meets Primary Endpoint in Brunello Diabetic Macular Edema Trial at One Year

Reuters
·
Yesterday

Merck Presents One-Year Results from the Pivotal Phase 2B/3 Brunello Study Evaluating Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at Aao 2026

THOMSON REUTERS
·
Yesterday

Merck & Co - Remigromig Demonstrates Non-Inferior Visual Acuity Versus Ranibizumab at One Year in Dme

THOMSON REUTERS
·
Yesterday

Shilpa Medicare’s Jadcherla Unit Wins European GMP Nod

TIPRANKS
·
Oct 10

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 10

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
Oct 10

Novartis AG Rises Friday, Outperforms Market

Dow Jones
·
Oct 10

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
Oct 10

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Oct 10

UBS Lifts AbbVie Target as Focus Expands Beyond Immunology Drugs

Reuters
·
Oct 09

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Oct 09

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Oct 09

Abbvie Inc. : UBS Raises Target Price to $275 from $260

THOMSON REUTERS
·
Oct 09

Merck & Company (MRK) Receives a Buy from UBS

TIPRANKS
·
Oct 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 09
More